11th Annual Meeting and Scientific Sessions
Quo VADis
Where Are We Going With MCS?
March 3 – 4, 2017, Atlanta, GA
Friday, March 3, 2017Pre-Sessions Symposium
11:30 AM Registration
12:00 PMPre-Sessions Symposium: Cost, Futility and Palliative CareRobert Kormos
- Prediction of FutilityFrancisPagani
2. Palliative Care in LVAD TherapyJames Kirkpatrick
Palliative Care along the VAD Journey
- Cost Data Models for LVADs
LVAD Program Financial DiscussionRobert Kormos
Cost Effectiveness in LVAD TherapyDipanjan Banerjee
- Case Study Review
2:00 PMAdjourn
11th Annual Meeting and Scientific Sessions
Quo VADis
Where Are We Going With MCS?
March 3 – 4, 2017, Atlanta, GA
Friday, March 3, 2017Annual Meeting and Scientific Sessions
2:25 PMRegistration
2:55 PMWelcome from National Heart, Lung and Blood Institute Marissa Miller
3:00 PMSession I: Registry Information
- Center PerformanceRyan Cantor
3:20 PMB. Web Based Reporting FeaturesDevin Koehl
Learn to Access and Analyze Your Center’s Data
4:10 PMC.Industry Vision for Mechanical Circulatory Support
Perspective from AbbottMark Carlson
Perspective from MedtronicThomas Vassiliades
Audience questions and comments
4:40 PMSession II: Rapid Fire Data Access, Analysis and Publications FrancisPagani /
SubmissionsJennifer Cowger
Characterizing the Process of Dying for Patients with an LVDColleen McIlvennan
Aortic InsufficiencyVeli Topkara
Predictors of Health Status Improvement after DT-LVADSuzanne Arnold
Infections in Children and Young AdultsSharon Chen
Which Intermacs 4-7 Patients Are at Low Risk for Mortality at Andrew Althouse
One Year
5:30 PMAdjourn
Reception to follow 5:45PM to 6:45PM
11th Annual Meeting and Scientific Sessions
Quo VADis
Where Are We Going With MCS?
March 3 – 4, 2017, Atlanta, GA
Saturday, March 4, 2017Annual Meeting and Scientific Sessions
7:00AM Registration
7:30 AMIntermacs and the Role of STSMarissa Miller
7:40 AMSession III: INTER –Agency and INTER-National LinksJames Young/
Joseph Rossano
Review Overall Intermacs and PedimacsData with HighlightsJamesKirklin
Current Status of VAD Centers in CanadaVivek Rao
IMACS UpdateJames Kirklin
Audience questions and comments
STS – Quality Initiatives in Cardiac Surgery Richard Prager
FDA – International HarmonizationJohn Laschinger
Audience questions and comments
8:55 AMSession IV: The Journey for Right Heart FailureKathleenSimpson /
Maryse Palardy
Context of RV failure in current HF JourneyLynne Stevenson
The science of the right ventricleAndrew Redington
Definitions of right heart failure after LVADWilson Grandin
Current Prevalence of RVF after VAD by definitionsEduardoRame
(Initial BiVAD, Late BiVAD, Inotropes Post VAD,Other Definitions)
Options for mechanical support for the right ventriclePavan Atluri
Audience questions and comments
9:50 AMBreak
10:05 AMSession V: Optimizing LVAD FunctionUlrich Jorde/
Christina VanderPluym
Using VAD Flow Curves to Adjust VAD DanielBurkhoff
Highs and Lows of Managing BP on the VAD (high and low)Jennifer Cowger
Optimizing Flow and Device Selection for Small BSAAngela Lorts
Audience questions and comments
10:50 AMSession VI: Events Happen Larry Allen/
Steven Kindel
The Picture of InfectionsWilliam Holman
Renal Dysfunction and Dialysis Before and After VADMary Keebler
Does Small BSA Lead to Small EventsDavidSutcliffe
Thromboembolic and Hemorrhagic StrokesPaolo Colombo
Audience questions and comments
11:35 AMSherri Ann Wissman Award
11:45 AMLunch (box lunches available for pickup)
12:15PMPanel LuncheonPavan Atluri
Discussion of Challenging Conditions: Decisions Related toVivek Rao
the Small Left VentricleJohn Stulak
EduardoRame
12:35 PMSession VII: Recovery FrancisPagani/
Sabrina Law
Key Note AddressStavros Drakos
“HF better EF” on Medical TherapyLynne Stevenson
Recovery to Discharge Home after ECMOAly El Banayosy
Do Children Recover More Often and More Fully Than Adults? Shelley Miyamoto
(ESLO, Temp Support Pedimacs)
Molecular and Structural Changes during LVADIki Adachi
Stem Cell to Support Recovery on LVADTerrence Yau
Audience questions and comments
1:50 PMBreak
2:05 PMSession VIII: Thrombosis James Kirklin/
Robert Jaquiss
Pump Thrombosis in Intermacs: A Problem Solved or Ongoing?Robert Kormos
What is the Answer to the Problem: Technology or Patient Management?
Perspectives from Trials of the HMII PumpJohn Stulak
Perspectives from Trials of the HVAD PumpJoseph Rogers
Perspectives from the Pumpkin Trial PatriciaMassicotte
Perspectives from Trials of the HM3 PumpMandeep Mehra
Panel Discussion
3:05 PMSession IX: Updates on thePatients Who Make Decisions ElizabethBlume/
Joseph Rogers
Who Came Out for the REVIVAL Maryse Palardy
Medamacs Outcomes at 1 Year Amrut Ambardekar
Turning off VADs – a palliative care representative Salpy Pamboukian
Ethics and Decision Making with and for Children Beth Kaufman
Can Patient Adversity be Modeled?James Antaki
To Guide, Aid, or Share Decisions? Larry Allen
Would you do it all again? Lynne Stevenson
Audience questions and comments
4:00 PMAdjourn
Version Date: 2/21/2017 1